{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:31:41Z","timestamp":1784874701036,"version":"3.55.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["NV 19-09-00125"],"award-info":[{"award-number":["NV 19-09-00125"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Research of Metabolic and Cardiovascular Diseases","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}]},{"name":"European Union\u2014Next Generation EU"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>While heart failure (HF) symptoms are associated with adverse prognosis after myocardial infarction (MI), they are not routinely used for patients\u2019 stratification. The primary objective of this study was to develop and validate a score to predict mortality risk after MI, combining remotely recorded HF symptoms and clinical risk factors, and to compare it against the guideline-recommended Global Registry of Acute Coronary Events (GRACE) score.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>A cohort study design using prospectively collected data from consecutive patients hospitalized for MI at a large tertiary heart centre between June 2017 and September 2022 was used. Data from 1135 patients (aged 64 \u00b1 12 years, 26.7% women), were split into derivation (70%) and validation cohort (30%). Components of the 23-item Kansas City Cardiomyopathy Questionnaire and clinical variables were used as possible predictors. The best model included the following variables: age, HF history, admission creatinine and heart rate, ejection fraction at hospital discharge, and HF symptoms 1 month after discharge including walking impairment, leg swelling, and change in HF symptoms. Based on these variables, the PragueMi score was developed. In the validation cohort, the PragueMi score showed superior discrimination to the GRACE score for 6 months [the area under the receiver operating curve (AUC) 90.1, 95% confidence interval (CI) 81.8\u201398.4 vs. 77.4, 95% CI 62.2\u201392.5, P = 0.04) and 1-year risk prediction (AUC 89.7, 95% CI 83.5\u201396.0 vs. 76.2, 95% CI 64.7\u201387.7, P = 0.004).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The PragueMi score combining HF symptoms and clinical variables performs better than the currently recommended GRACE score.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwae114","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T08:44:20Z","timestamp":1710751460000},"page":"1713-1720","source":"Crossref","is-referenced-by-count":4,"title":["Development and validation of a prognostic score integrating remote heart failure symptoms and clinical variables in mortality risk prediction after myocardial infarction: the PragueMi score"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-526X","authenticated-orcid":false,"given":"Peter","family":"Wohlfahrt","sequence":"first","affiliation":[{"name":"Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine , Videnska 1958\/9, Prague 140 21 ,","place":["Czech Republic"]},{"name":"First Medical School, Charles University , Katerinska 1660\/32, Prague 120 00 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Jen\u010da","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]},{"name":"Third Medical School, Charles University , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojt\u011bch","family":"Melenovsk\u00fd","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Stehlik","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Utah School of Medicine , Salt Lake City, UT ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolana","family":"Mr\u00e1zkov\u00e1","sequence":"additional","affiliation":[{"name":"Experimental Medicine Centre, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"\u0160ramko","sequence":"additional","affiliation":[{"name":"First Medical School, Charles University , Katerinska 1660\/32, Prague 120 00 ,","place":["Czech Republic"]},{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kotr\u010d","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"\u017del\u00edzko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u011bra","family":"Ad\u00e1mkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Preventive Cardiology, Institute for Clinical and Experimental Medicine , Videnska 1958\/9, Prague 140 21 ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pi\u0165ha","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1632-6182","authenticated-orcid":false,"given":"Josef","family":"Kautzner","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM) , Prague ,","place":["Czech Republic"]},{"name":"Medical and Dentistry School, Palack\u00fd University , Olomouc ,","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"2024101001381631300_zwae114-B1","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2024101001381631300_zwae114-B2","article-title":"Impact of anaemia and iron deficiency on outcomes in cardiogenic shock complicating acute myocardial infarction","author":"Obradovic","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2024101001381631300_zwae114-B3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","article-title":"Heart failure after myocardial infarction: incidence and predictors","volume":"8","author":"Jen\u010da","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2024101001381631300_zwae114-B4","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCHEARTFAILURE.115.002460","article-title":"Mortality associated with heart failure after myocardial infarction: a contemporary community perspective","volume":"9","author":"Gerber","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2024101001381631300_zwae114-B5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00392-022-02008-z","article-title":"Heart failure-related quality-of-life impairment after myocardial infarction","volume":"112","author":"Wohlfahrt","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2024101001381631300_zwae114-B6","doi-asserted-by":"crossref","first-page":"e032505","DOI":"10.1161\/JAHA.123.032505","article-title":"Remote heart failure symptoms assessment after myocardial infarction identifies patients at risk for death","volume":"13","author":"Wohlfahrt","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2024101001381631300_zwae114-B7","doi-asserted-by":"crossref","first-page":"1051995","DOI":"10.3389\/fcvm.2022.1051995","article-title":"Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions","volume":"9","author":"Wohlfahrt","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2024101001381631300_zwae114-B8","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation"},{"key":"2024101001381631300_zwae114-B9","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"2024101001381631300_zwae114-B10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"2024101001381631300_zwae114-B11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/bimj.200610301","article-title":"Consistent estimation of the expected Brier score in general survival models with right-censored event times","volume":"48","author":"Gerds","year":"2006","journal-title":"Biom J"},{"key":"2024101001381631300_zwae114-B12","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/sim.5647","article-title":"A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data","volume":"32","author":"Uno","year":"2013","journal-title":"Stat Med"},{"key":"2024101001381631300_zwae114-B13","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/01.CIR.0000017861.00991.2F","article-title":"Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure","volume":"105","author":"Spencer","year":"2002","journal-title":"Circulation"},{"key":"2024101001381631300_zwae114-B14","first-page":"578-585","article-title":"Symptoms and signs in patients with heart failure: association with 3-month hospitalisation and mortality","volume":"110","author":"Mohammad Rizwan","year":"2024","journal-title":"Heart"},{"key":"2024101001381631300_zwae114-B15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.hfc.2020.06.002","article-title":"Empowering people living with heart failure","volume":"16","author":"Wohlfahrt","year":"2020","journal-title":"Heart Fail Clin"},{"key":"2024101001381631300_zwae114-B16","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIRCULATIONAHA.106.670901","article-title":"Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments","volume":"115","author":"Kosiborod","year":"2007","journal-title":"Circulation"},{"key":"2024101001381631300_zwae114-B17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/01.CIR.0000136991.85540.A9","article-title":"Prognostic value of health status in patients with heart failure after acute myocardial infarction","volume":"110","author":"Soto","year":"2004","journal-title":"Circulation"},{"key":"2024101001381631300_zwae114-B18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"Lancet"},{"key":"2024101001381631300_zwae114-B19","doi-asserted-by":"crossref","first-page":"100933","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis","volume":"36","author":"Cardoso","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2024101001381631300_zwae114-B20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"key":"2024101001381631300_zwae114-B21","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1016\/S2589-7500(21)00228-4","article-title":"Development and validation of an artificial neural network algorithm to predict mortality and admission to hospital for heart failure after myocardial infarction: a nationwide population-based study","volume":"4","author":"Mohammad","year":"2022","journal-title":"Lancet Digit Health"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwae114\/57131023\/zwae114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/14\/1713\/59648640\/zwae114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/31\/14\/1713\/59648640\/zwae114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T11:34:01Z","timestamp":1728560041000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/31\/14\/1713\/7630700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":21,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,3,18]]},"published-print":{"date-parts":[[2024,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwae114","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,3,18]]}}}